Solid Biosciences Reports Efficacy and Safety Data from the Ongoing IGNITE DMD Clinical Trial and Resumption of Patient Dosing in the 2E14 vg/kg Cohort - CureDuchenne
Phase 3 Trial of Pamrevlumab Enrolling DMD Patients Unable to Walk
About Clinical Trials – Defeat Duchenne Canada
Solid Provides IGNITE DMD Phase I/II Clinical Trial and Pipeline Update - Parent Project Muscular Dystrophy
Promising gene therapy for Duchenne muscular dystrophy
Inclusion and exclusion criteria in PhaseOut DMD trial with ezutromid. | Download Scientific Diagram
Genome editing for Duchenne muscular dystrophy: a glimpse of the future? | Gene Therapy
Development of Vamorolone
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug - ScienceDirect
EXPLORE DMD | Clinical Trials
Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy: Molecular Therapy
DMD: gene therapy clinical trial starting in France - Institut de Myologie
IGNITE DMD Phase I/II Clinical Trial Update - CureDuchenne
Sustained Gains for Duchenne Boys Evident in Gene Therapy Trials
Duchenne Muscular Dystrophy - Capricor
Pfizer initiates dosing in Duchenne muscular dystrophy gene therapy trial
Viltolarsen & Duchenne Muscular dystrophy | CPAA
Clinical trials ongoing and listed in http://clinicaltrials.gov... | Download Table
Measurements Used in Clinical Trials for Duchenne Muscular Dystrophy – an Overview | Sarepta Corporate Rebuild
Ongoing clinical trials for DMD/BMD and LGMD diseases. The current... | Download Scientific Diagram
Duchenne clinical trial offers promising results using unique therapy
Clinical Trials - ReveraGen BioPharma
News | Duchenne Research Fund
